Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chimerix, Inc.
Chimerix acquires lead compound library of antiviral agents from University of Michigan
June 23rd, 2006
Chimerix, Inc., an emerging biotechnology company developing orally available antiviral therapeutics, announced that it has acquired Dr. Leroy Townsend's lifetime library of chemical lead compounds from the University of Michigan, including an option to all associated intellectual property. The library, developed by Townsend, consists of lead candidates specifically designed toward key antiviral and oncology targets. Chimerix will incorporate promising candidates from the antiviral library into the company's technology platform, which enables the development of drugs with enhanced chemical properties, including oral availability and facilitated delivery into targeted...
Source: Biotech Law Weekly (2006-06-23)
|
